Adopting the ‘cascade of care’ framework: an opportunity to close the implementation gap in addiction care?
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Despite a growing number of evidenced-based addiction treatments, a substantial implementation gap in addiction medicine remains. The 'cascade of care' framework can serve as a tool to identify gaps along the continuum of care and tailor interventions to improve the quality of addiction care and outcomes. According to recent estimates, there are approximately between 73 and 81 million individuals with alcohol use disorders, and 16–19 million with substance use disorders (SUD) related to illicit drugs globally 1, 2. These numbers, alongside the numerous direct and indirect adverse health and social consequences arising from untreated SUD, translate into a significant and growing disease and economic burden 1, 3. Unfortunately, despite the growing availability of evidence-based behavioural and pharmacotherapeutic interventions for the treatment and prevention of SUD, a substantial implementation gap in addiction medicine remains 4, 5. This results in only a minority of the more than 80 million individuals with substance use disorders world-wide receiving evidence-based treatments. Indeed, it is estimated that only one-sixth of individuals with SUD access treatment each year, with large regional variations, ranging from fewer than 5% in Africa to up to 25% in western Europe and North America 2. Even these figures are likely to be overestimations, as suggested by recent US data indicating that from the estimated 22.5 million individuals with SUD in the United States, only approximately 12% received treatment in 2014 6, of whom only a fraction are likely to have received evidence-based treatments matched to disease severity. Factors underpinning this gap are numerous, and span throughout and beyond the health system, including a historical lack of addiction medicine training in the health-care work-force, traditional restrictions on coverage for addiction treatment, as well as the criminalized and stigmatized nature of substance use that can act as important deterrent of health-care-seeking among individuals with SUD 3, 4, 7. Encouragingly, increasing recognition of SUD as a chronic disease requiring comprehensive continuing care approaches rather than simplistic detoxification strategies have led to the development and scale-up of addiction medicine training programmes, as well as to regulations expanding health-care coverage for SUD in many settings 4, 7-10. In this context, monitoring the quality of addiction care will be critical to assess the success of these emerging and future efforts towards closing the implementation gap between research evidence and access to evidence-based addiction care. Despite the essential role of measurement to improve the quality of health-care delivery, the SUD field has lagged behind in this area 7. Thus, to further these efforts, it might be necessary to draw upon lessons from other fields. For instance, the 'cascade of care' has emerged as a useful tool to monitor system-wide effectiveness and performance across key stages of the continuum of care for certain chronic diseases. The 'cascade of care' was proposed originally as a key metric to assess the quality of HIV care delivery, from HIV diagnosis to access and retention in care and treatment, to viral suppression, the ultimate goal in HIV care to improve survival and reduce HIV transmission 11. Identification of stages where major gaps occur along the continuum, in turn, can help in the design of targeted interventions to address them. Further, when standardized metrics are used, they can serve to track progress over time, as well as to compare results across subpopulations and settings. Indeed, the cascade framework has been adopted increasingly by national governments and international agencies to track the progress of the HIV response over time 12. For example, Fig. 1a shows data for a recently estimated US HIV 'cascade of care', which demonstrates shortfalls between current estimates and recently defined targets 13. The 'cascade of care' framework has been adapted recently to other chronic communicable and non-communicable diseases, including hepatitis C 14 and diabetes 15. US 'cascades of care' for these diseases have also pointed to major gaps between current care and recommended treatment goals 14, 15. Existing estimates and a hypothetical cascade of care for SUD in the United States are presented in Fig. 1b, highlighting the lack of available data to populate most of the steps in a recovery-orientated system of care. Understanding the present status of the local epidemic and identification of priority needs is a crucial first step to inform programme planning and evaluate the impact of quality improvement efforts. As such, spearheading the use of the 'cascade of care' framework in addiction care may be a unique opportunity to increase public and political awareness of the public health importance of SUD, advocate for resources and set treatment targets. Extending the 'cascade of care' framework to addiction care w
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Cited by
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32229-9 · Cited by 832
Development of a Cascade of Care for responding to the opioid epidemic.
Williams, A. R., Nunes, E. V., Bisaga, A., Levin, F. R., & Olfson, M. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2018.1546862 · Cited by 332
Treatment for Opioid Use Disorder: Population Estimates — United States, 2022
Dowell, D., Brown, S., Gyawali, S., Hoenig, J., Ko, J., Mikosz, C., Ussery, E., Baldwin, G., Jones, C. M., Olsen, Y., et al. (2024) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7325a1 · Cited by 261
Self-citationSamples, H., Williams, A. R., Olfson, M., & Crystal, S. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.09.001 · Cited by 235
Targeting the Barriers in the Substance Use Disorder Continuum of Care With Peer Recovery Support
Stanojlović, M., & Davidson, L. (2021) · Substance Abuse: Research and Treatment · doi:10.1177/1178221820976988 · Cited by 93
Reilly, J., Meurk, C., Sara, G. E., & Heffernan, E. (2025) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674241312790 · Cited by 4
“…SUD disorders with other mental and behavioural disorders can support targeted system-wide improvement for identification and treatment processes, linking with processes, such as stepped care (Gordon et al., 2020) and improvement linked cascades of care (Socías et al., 2016; Williams et al., 2018).”
Diabetic retinopathy treatment cascade and care continuum in the USA: a systematic review
Fu, J. J., Applebaum, S. S., Granados, A., & Nwanyanwu, K. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-117683 · Cited by 1
Metadata
- Authors
- Socías, M. E., Volkow, N., & Wood, E.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2016-07-13
- Volume
- 111
- Issue
- 12
- Pages
- 2079-2081
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2471345596
- Cited by
- 89
- References
- 1
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.